Impacting Millions: Human Insulin’s Surprising Resilience to Temperature Variations

by Klaus Müller
Insulin Stability

A recent evaluation conducted by Cochrane has uncovered a remarkable revelation concerning the stability of insulin, a critical medication for individuals with diabetes. Contrary to previous assumptions, certain varieties of insulin demonstrate resilience when stored at room temperature for extended durations. This development holds profound implications for diabetes care, particularly in regions lacking reliable refrigeration facilities.

The study in question, undertaken by Bernd Richter and his team from the Institute of General Practice, Medical Faculty of the Heinrich-Heine-University in Düsseldorf, Germany, delves into the resilience of insulin under diverse storage conditions. This comprehensive review scrutinized seventeen separate studies, encompassing laboratory examinations of insulin vials, cartridges/pens, and prefilled syringes. Astonishingly, these investigations consistently affirmed the potency of insulin across a spectrum of temperatures, ranging from 4°C to 37°C, with no clinically significant decline in insulin activity.

For individuals afflicted with diabetes, insulin is an indispensable lifeline. Those with type 1 diabetes, in particular, rely on frequent insulin injections to manage their condition. It is a well-established protocol that insulin must be refrigerated to maintain its efficacy before use. However, millions of people residing in low- and middle-income countries face the stark reality of limited access to electricity and refrigeration. Furthermore, populations enduring conflict zones, natural disasters, or the brunt of climate crises often lack the luxury of powered refrigeration.

The groundbreaking Cochrane review offers a glimmer of hope to these underserved communities. It consolidates the findings of various studies, including hitherto unpublished data from insulin manufacturers. Notably, it suggests that specific types of human insulin can be safely stored at temperatures of up to 25°C for a maximum of six months and up to 37°C for up to two months, all without experiencing any clinically significant degradation in insulin activity. Remarkably, one study demonstrated the absence of insulin activity loss even when subjected to fluctuating ambient temperatures between 25°C and 37°C for up to three months, resembling the diurnal temperature fluctuations in tropical regions.

This revelation underscores the pressing need for clear guidance to be disseminated to individuals facing critical life situations and hailing from regions that lack official sources of information. For people with type 1 diabetes, insulin is not merely a medical treatment; it is a lifeline, their very survival depends on it.

The implications extend beyond mere theoretical knowledge. They pave the way for innovative solutions in insulin storage for challenging environments. If reliable refrigeration is unattainable, the study proposes the utilization of simple cooling devices such as clay pots for insulin preservation. Moreover, these findings spotlight areas of future research, including mixed insulin’s stability, the influence of motion on insulin effectiveness (as observed in insulin pumps), contamination in opened vials and cartridges, and investigations into cold environmental conditions.

In conclusion, the Cochrane review, funded by the World Health Organization, has illuminated a new path for individuals in resource-constrained settings. It offers the reassurance that alternatives to powered refrigeration for insulin storage are not only possible but also safe. As we delve deeper into the intricacies of insulin stability, we take significant strides toward enhancing the lives of those who depend on this vital medication for their well-being.

Reference: “Thermal stability and storage of human insulin” by Bernd Richter, Brenda Bongaerts, and Maria-Inti Metzendorf, November 6, 2023, Cochrane Database of Systematic Reviews.
DOI: 10.1002/14651858.CD015385.pub2

Frequently Asked Questions (FAQs) about Insulin Stability

What did the Cochrane review discover about insulin storage?

The Cochrane review found that certain types of human insulin can be stored at temperatures of up to 25°C for a maximum of six months and up to 37°C for up to two months without any clinically relevant loss of insulin activity.

Why is this discovery significant for individuals with diabetes?

This discovery is significant because it offers hope for individuals with diabetes living in areas with limited access to healthcare or stable refrigeration. It means they can potentially store insulin at room temperature, which is often not feasible in resource-constrained regions.

How does the lack of reliable refrigeration impact diabetes care?

In many low- and middle-income countries and in regions affected by conflict or natural disasters, reliable refrigeration is often unavailable. This poses a significant challenge for individuals with diabetes who require insulin, as insulin’s efficacy is typically preserved through refrigeration.

What are the potential implications of this discovery for diabetes care?

This discovery opens up possibilities for more accessible and reliable storage of insulin in challenging environments. It suggests that simple cooling devices, such as clay pots, could be used for insulin storage in areas where powered refrigeration is not feasible.

What areas of future research are highlighted in this study?

The study highlights several areas for future research, including investigating the stability of mixed insulin, understanding the influence of motion on insulin effectiveness (as observed in insulin pumps), addressing contamination issues in opened insulin vials and cartridges, and exploring insulin’s stability under cold environmental conditions.

How can this research benefit individuals with type 1 diabetes?

For individuals with type 1 diabetes, insulin is a lifeline, and their lives depend on it. This research provides valuable insights into ensuring the availability and effectiveness of insulin in critical life situations, which is essential for those with type 1 diabetes.

More about Insulin Stability

You may also like


ScienceNerd1 December 25, 2023 - 11:25 am

Future research = crucial. Mixed insulins, motion effct, contam, cold enviro. Need to know more!

Reader123 December 25, 2023 - 2:17 pm

wow, dis study say insuline ok in hot room?! hope dis help diabeet people no fridge

Type1Warrior December 25, 2023 - 7:41 pm

Insulin = lifeline. Glad 4 this news, helps peeps like me. #Type1Diabetes

MedStudent2022 December 25, 2023 - 10:53 pm

gr8 info for med studnts. insuln stability key 4 diabetics in tough situs.

HealthGeek47 December 26, 2023 - 4:30 am

This is amazin’ news! I mean, insulin, room temp, safe? Great for low income places!


Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

SciTechPost is a web resource dedicated to providing up-to-date information on the fast-paced world of science and technology. Our mission is to make science and technology accessible to everyone through our platform, by bringing together experts, innovators, and academics to share their knowledge and experience.


Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

© 2023 SciTechPost